SUBSCRIBE
SUBSCRIBE
News   Drug Development

Roche Holding’s Tamiflu Doesn’t Need New Safety Information, Panel Says

December 15, 2005 | 
1 min read
Dec. 15 (Bloomberg) -- Roche Holding AG's Tamiflu treatment, being stockpiled worldwide for use in a potential avian influenza epidemic, doesn't need extra safety information on its label, a European Union regulatory panel ruled.
Clinical research Postmarket research Regulatory
MORE ON THIS TOPIC
Profile view, and Mental Illness
Depression
Alto Digs Into Exploratory Outcomes as Depression Drug Misses Phase II Endpoint
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump’s CDC Pick Says Vaccines Are Safe, Promises To Keep Them Available
June 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac